Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06173973

Effects of Ketone Supplementation on Acute Alcohol Withdrawal

Effects of Ketone Supplementation on Acute Alcohol Withdrawal Symptoms During Alcohol Withdrawal Management

Status
Enrolling By Invitation
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to study the effects of the ketone supplement Kenetik compared to placebo (an inactive beverage) on alcohol withdrawal symptoms during the 5 days of clinical alcohol withdrawal management treatment at the Caron Treatment Center.

Detailed description

This is a 5 day double-blinded, placebo-controlled intervention study of 50 treatment-seeking individuals with AUD, who are receiving detoxification treatment at Caron Treatment Center. Participants will be recruited for participation within 48 hours of admission to the inpatient unit. Participants will be consented and randomized to receive 10 g of ketone supplement three times daily (n=30; 1,3-butanediol and D-hydroxybutyric acid from Kenetik, VitaNav Inc., Washington D.C.) for 5 days or a placebo beverage (n=20). Benzodiazepines and other "comfort" medications will be administered daily following the Caron withdrawal management protocol, with additional benzodiazepines administered based on withdrawal symptoms, monitored with the revised Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar). The CIWA-Ar is given three or more times per day clinically to determine patient withdrawal levels and adjust medication dosages. Total daily maximum CIWA-Ar scores, benzodiazepine dosage and other "comfort" medications will be analyzed with a repeated measures design, with a binary factor for intervention, factor of time, and intervention by time interaction. Daily mood and alcohol craving questions will assess differences between treatment groups.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKenetik; Ketone ConcentrateKetone Supplement
DIETARY_SUPPLEMENTIsocaloric dextrose placeboDrink that is taste and visually matched to Ketone supplement

Timeline

Start date
2024-03-11
Primary completion
2026-12-01
Completion
2027-12-01
First posted
2023-12-18
Last updated
2026-04-06

Locations

2 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06173973. Inclusion in this directory is not an endorsement.